Thirty-one patients with glioblastoma multiforme treated at the Middle Atlantic Neutron Therapy Association (MANTA) are reported. All but one patient completed a prescribed course of treatment, and most demonstrated clinical improvement. Mean survivals of 11.1 months for Grade III neutron-treated patients and 6.8 months for Grade IV patients were obtained. Persistent tumor in seven of eight patients was confirmed by biopsy or autopsy.
No takes yet. Share an insight, caveat, or question.
Herskovic et al. (1982) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: